Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) is Other Consumer Non-Durables in Canada that focus on derivative products business. They cover business area such as cannabis, Canada, research, development, production, extraction, cultivation, planting, processing, marketing, high-content CBD industrial cannabi.
-
Derivative Products
-
British Columbia
Canada
Private
cannabisCanadaresearchdevelopmentproductionextractioncultivationplantingprocessingmarketinghigh-content CBD industrial cannabi
* We use standard office opening hours in near Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) is Other Consumer Non-Durables business from Canada that founded in - ( years old in ), Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) business is focusing on Derivative Products.
Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) headquarter office and corporate office address is located in British Columbia Canada.
Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) was founded in Canada.
In , Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai) is currently focus on derivative products sector.
Above is snippet of Google Trends for "derivative products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Medicinal CBD Commercialization (Benchmark / Zhejiang Yatai), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
